Literature DB >> 21116408

Effect of marine polyunsaturated fatty acids on biofilm formation of Candida albicans and Candida dubliniensis.

Vuyisile S Thibane1, Johan L F Kock, Ruan Ells, Pieter W J van Wyk, Carolina H Pohl.   

Abstract

The effect of marine polyunsaturated fatty acids on biofilm formation by the human pathogens Candida albicans and Candida dubliniensis was investigated. It was found that stearidonic acid (18:4 n-3), eicosapentaenoic acid (20:5 n-3), docosapentaenoic acid (22:5 n-3) and docosahexaenoic acid (22:6 n-3) have an inhibitory effect on mitochondrial metabolism of both C. albicans and C. dubliniensis and that the production of biofilm biomass by C. dubliniensis was more susceptible to these fatty acids than C. albicans. Ultrastructural differences, which may be due to increased oxidative stress, were observed between treated and untreated cells of C. albicans and C. dubliniensis with formation of rough cell walls by both species and fibrillar structures in C. dubliniensis. These results indicate that marine polyunsaturated fatty acids may be useful in the treatment and/or prevention of biofilms formed by these pathogenic yeasts.

Entities:  

Keywords:  Candida albicans; Candida dubliniensis; polyunsaturated fatty acids

Mesh:

Substances:

Year:  2010        PMID: 21116408      PMCID: PMC2992994          DOI: 10.3390/md8102597

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


1. Introduction

Candida albicans and Candida dubliniensis are dimorphic yeasts, able to grow both as yeasts and mycelia. Several members of the genus Candida exist as commensals of the human gastrointestinal and genitourinary tract in healthy individuals [1-3]. However, in individuals whose immune system is compromised, such as those that are HIV positive, C. albicans can cause diseases ranging from superficial infections to deep seated mycoses [4,5]. Candida dubliniensis is a species closely related to C. albicans and a causative agent of oropharyngeal candidiasis in immunocompromised humans [5,6]. Biofilm formation is a major virulence factor in the pathogenicity of Candida species, partly due to their increased resistance to antifungal treatment [7,8]. Since biofilm associated infections have many clinical and economic consequences, recent research into the pathogenicity of Candida species has focused on the prevention and management of these biofilms. Fatty acids have been known to have antibacterial [9] and antifungal properties and especially capric acid (10:0) and lauric acid (12:0) are known to have anti-Candida effects by inhibiting growth of planktonic cells [10] and butyric acid (4:0) was shown to inhibit hyphal formation by C. albicans [11]. Marine lipids, such as fish oils, are well known sources of medium to long chain polyunsaturated fatty acids (PUFAs) and are enriched in n-3 PUFAs [i.e., stearidonic acid (18:4 n-3), eicosapentaenoic acid (20:5 n-3), docosapentaenoic acid (22:5 n-3) and docosahexaenoic acid (22:6 n-3)] [12]. In addition, marine algae provide alternative sources of these n-3 PUFAs [13]. The lipid compositions and quantity of marine lipids vary depending on species and climatic conditions, with lipids from organisms in colder regions having a higher PUFA content than those in warmer regions [14,15]. Although some marine PUFAs have beneficial effects in several human diseases [16-18], the effectiveness of marine PUFAs against Candida biofilms have not been assessed previously. Therefore, the aim of this study was to determine the effect of long chain marine PUFAs [18:4 n-3, arachidonic acid (20:4 n-6), 20:5 n-3, 22:5 n-3 and 22:6 n-3] on biofilm formation by C. albicans and C. dubliniensis.

2. Results and Discussion

2.1. Inhibition of mitochondrial metabolism

As indicated in Figure 1 the mitochondrial metabolism of biofilms of C. albicans and C. dubliniensis, assessed by XTT assay, was significantly inhibited by 1 mM 18:4 n-3, 20:5 n-3 and 22:5 n-3. In addition, biofilms of C. albicans were also sensitive to 20:4 n-6, while biofilms of C. dubliniensis were not significantly inhibited. Interestingly, 22:6 n-3 did not significantly inhibit mitochondrial metabolism of C. albicans or C. dubliniensis biofilms. As a result 20:4 n-6 and 22:6 n-3 were not used in further experiments.
Figure 1

Effect of marine fatty acids (18:4 n-3, 20:4 n-3, 20:5 n-3, 22:5 n-3, 22:6 n-3) on mitochondrial metabolism of C. albicans and C. dubliniensis biofilms. Biofilms were grown in the presence of 1 mM of the fatty acids and mitochondrial activity was monitored using the XTT assay. The percentage inhibition values were determined compared to untreated controls. n = 8; * significantly different from control (P ≤ 0.01).

2.2. Inhibition of biomass production

Although several authors use the XTT reduction assay as an indicator of biofilm biomass, Kuhn and co-workers [19] has cautioned against this approach. Therefore, the effect of the marine PUFAs on biofilm biomass production was determined by dry weight. As indicated in Figure 2, biofilm biomass production by C. dubliniensis was susceptible to the three tested PUFAs, with 18:4 n-3 and 20:5 n-3 resulting in a reduction of circa 82% and 71%, respectively. C. dubliniensis biofilm biomass was less susceptible to 22:5 n-3, which produced an inhibition of circa 19%. Similar results were obtained between the two species for the XTT reduction assay, however, the biofilm biomass of C. albicans was generally less susceptible to the tested PUFAs and a reduction of only circa 25% and 22% was seen for 18:4 n-3 and 22:5 n-3, respectively. Although a circa 16% reduction in C. albicans biofilm biomass was observed with 20:5 n-3, this was not statistically significant. These results may indicate the increased ability of the C. albicans strain to obtain energy through pathways that do not require mitochondrial metabolism.
Figure 2

Inhibition of biofilm biomass of C. albicans and C. dubliniensis compared to untreated controls. Biofilms were grown in the presence of 1 mM of the marine PUFAs (18:4 n-3, 20:5 n-3, 22:5 n-3) and biofilm dry weight was determined on pre-weighed filters. n = 2.

2.3. Morphology of cells in biofilms

Figure 3 depicts biofilms of C. albicans grown in the presence and absence of 1 mM 18:4 n-3, 20:5 n-3 and 22:5 n-3. In the absence of the PUFAs, the cell surface appeared smooth (Figure 3a) and when grown in the presence of PUFAs, cells had a rough appearance with protuberances (Figure 3b, c, d). Similar results were also observed for biofilms of C. dubliniensis when grown in the absence (Figure 4a), and the presence (Figure 4b, c, d), of the PUFAs with protuberances and fibrillar structures visible on the cell surface. Similar rough cell surfaces were observed when C. albicans was exposed to miconazole [20], which is known to cause an increase in reactive oxygen species in Candida biofilm cells [21]. Lemar et al. [22] also found that C. albicans cells were not smooth in the presence of alyl alcohol, which increases oxidative stress. Furthermore, in a study by Leeuw et al. [23] on the yeast Cryptococcus curvatus grown on oxidised lipids, protuberances were observed on the cell surface. We therefore speculate that the changes in cell surface in the presence of PUFAs might be due to increased lipid peroxidation and resultant oxidative stress. This will be studied in future.
Figure 3

SEM micrograps showing cells of C. albicans control biofilms (a) and biofilms treated with 1 mM 18:4 n-3 (b), 20:5 n-3 (c) and 22:5 n-3 (d).

Figure 4

SEM micrographs showing cells of C. dubliniensis control biofilms (a) and biofilms treated with 1mM 18:4 n-3 (b), 20:5 n-3 (c) and 22:5 n-3 (d).

3. Experimental

3.1. Strains used

Candida albicans CBS 562T and Candida dubliniensis NRRL Y-17841T were used in this study and were maintained on yeast malt extract (YM) agar plates (10 g/L glucose, 3 g/L yeast extract, 3 g/L malt extract, 5 g/L peptone, 16 g/L agar) at room temperature. The strains were stored on agar slants at 4 °C.

3.2. XTT assay of biofilms

Cells of C. albicans and C. dubliniensis were grown separately on YM agar plates and incubated at 30 °C for 24 hours. After incubation, a loop-full of the cells was inoculated into 20 mL of yeast nitrogen base (YNB) glucose medium (10 g/L glucose, 6.7 g/L YNB) and incubated for 48 hours at 30 °C. Cells were washed three times with phosphate buffered saline (PBS) and diluted in RPMI-1640 medium (Sigma-Aldrich, UK) to an initial cell concentration of 1 × 106 cells/mL. A volume of 100 μL of the standardized cell suspension was dispensed into a 96-well microtiter plate (Corning Incorporated, Costar®, U.S.) and incubated for 1 hour at 37 °C to allow adherence of cells to the surface [24]. Wells were washed twice with PBS to remove non-adherent cells. Mature biofilms were formed at 37 °C for 47 hours in the presence and absence of 1 mM of the marine fatty acids (18:4 n-3, 20:4 n-3, 20:5 n-3, 22:5 n-3, 22:6 n-3) (Sigma-Aldrich, UK). The reduction of (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide) (XTT) (Sigma Aldrich) was used to examine the yeast viability by measuring the mitochondrial metabolic activity of the biofilms, according to the method of Kuhn et al. [19]. XTT is converted to the diffusible, water soluble formazan that is colored and is easily measured in cellular supernatants in terms of optical density at 492 nm. This experiment was done in duplicate on two different days and four values obtained for each repetition (n = 8). The average and standard deviations were calculated and the student’s t-test was used to determine the significance of data sets.

3.3. Biomass determination

Twenty milliliters of a standardized cell suspension (1 × 106 cells/mL), prepared as before, was inoculated into Petri dishes containing RPMI-1640 medium and allowed to adhere to the surface for 1 hour at 37 °C. Non-adherent cells were removed with PBS and mature biofilms were formed in the presence of 1 mM of the marine fatty acids (18:4 n-3, 20:5 n-3, 22:5 n-3) for 47 hours at 37 °C. Untreated biofilms served as controls. Mature biofilms were washed to remove non-adherent cells, scraped off and resuspended in PBS. Cells were filtered on pre-weighed 0.2 μm cellulose acetate filters (Lasec, SA). The filters were dried to constant weight for 48 hours at 37 °C and the biomass determined. This experiment was done in duplicate and the mean and range calculated.

3.4. Morphological examination

The standardized cell suspension (1 × 106 cells/mL), prepared as before, was added to chamber slides (Lab-Tek® Chamber Slide™ System 177372) containing silicone rubber disks (diam 5.5 mm) and 4 mL RPMI-1640 medium. Cells were allowed to adhere for 1 hour at 37 °C. Non-adherent cells were removed with PBS and mature biofilms were formed in the presence of 1 mM of the marine fatty acids (18:4 n-3, 20:5 n-3, 22:5 n-3) for 47 hours at 37 °C, with appropriate controls. The silicone rubber disks were removed and fixed for 2 hours using 3% (v/v; 1.0 M) sodium phosphate buffered glutardialdehyde, followed by fixing for 1 hour with a similarly buffered solution of osmium tetroxide (1% m/v). The disks were dehydrated in a graded series of ethanol solutions (50%, 70% and 95%) for 20 minutes and absolute ethanol for 1 hour. They were then critical-point dried, mounted and coated with gold to make them electrically conductive and finally visualized on a Shimadzu SSX550 SEM (Japan) microscope according to the method of van Wyk and Wingfield [25].

4. Conclusions

Certain marine PUFAs, especially 18:4 n-3, 20:5 n-3 and 22:5 n-3, have an inhibitory effect on the mitochondrial activity of both C. albicans and C. dubliniensis biofilms and significantly inhibited biofilm biomass of C. dubliniensis. These marine PUFAs also affected cellular morphology of biofilms of both species. This may be due to increased oxidative stress as a result of incorporation of PUFAs into the cellular lipids. These findings suggest that marine PUFAs may be useful in the treatment and/or prevention of Candida biofilms, which are known to have increased antifungal resistance compared to free-living cells.
  20 in total

Review 1.  Candida biofilms and their susceptibility to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole.

Authors:  S De Nollin; M Borgers
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

Authors:  Penny M Kris-Etherton; William S Harris; Lawrence J Appel
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

4.  Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

Authors:  D Neofytos; J A Fishman; D Horn; E Anaissie; C-H Chang; A Olyaei; M Pfaller; W J Steinbach; K M Webster; K A Marr
Journal:  Transpl Infect Dis       Date:  2010-01-25       Impact factor: 2.228

5.  Biofilm formation by Candida dubliniensis.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Regulation of Candida albicans morphogenesis by fatty acid metabolites.

Authors:  Mairi C Noverr; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 7.  Candida Albicans: a molecular revolution built on lessons from budding yeast.

Authors:  Judith Berman; Peter E Sudbery
Journal:  Nat Rev Genet       Date:  2002-12       Impact factor: 53.242

Review 8.  Candida albicans: genetics, dimorphism and pathogenicity.

Authors:  G Molero; R Díez-Orejas; F Navarro-García; L Monteoliva; J Pla; C Gil; M Sánchez-Pérez; C Nombela
Journal:  Int Microbiol       Date:  1998-06       Impact factor: 2.479

9.  In vitro killing of Candida albicans by fatty acids and monoglycerides.

Authors:  G Bergsson; J Arnfinnsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Uses and limitations of the XTT assay in studies of Candida growth and metabolism.

Authors:  D M Kuhn; M Balkis; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  15 in total

1.  Antibiofilm Activity of Essential Fatty Acids Against Candida albicans from Vulvovaginal Candidiasis and Bloodstream Infections.

Authors:  Shuai Wang; Peng Wang; Jun Liu; Chunxia Yang; Qiangyi Wang; Mingze Su; Ming Wei; Li Gu
Journal:  Infect Drug Resist       Date:  2022-08-03       Impact factor: 4.177

2.  The Antimicrobial Peptides P-113Du and P-113Tri Function against Candida albicans.

Authors:  Guan-Yu Lin; Hsueh-Fen Chen; Yao-Peng Xue; Ying-Chieh Yeh; Chia-Lu Chen; Ming-Sun Liu; Wen-Chi Cheng; Chung-Yu Lan
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 3.  Controlling biofilms using synthetic biology approaches.

Authors:  Kuili Fang; Oh-Jin Park; Seok Hoon Hong
Journal:  Biotechnol Adv       Date:  2020-01-15       Impact factor: 14.227

4.  Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.

Authors:  Shaimaa Mosallam; Maha H Ragaie; Noha H Moftah; Ahmed Hassen Elshafeey; Aly Ahmed Abdelbary
Journal:  Int J Nanomedicine       Date:  2021-01-08

5.  A New Bioactive Compound From the Marine Sponge-Derived Streptomyces sp. SBT348 Inhibits Staphylococcal Growth and Biofilm Formation.

Authors:  Srikkanth Balasubramanian; Joseph Skaf; Ulrike Holzgrabe; Richa Bharti; Konrad U Förstner; Wilma Ziebuhr; Ute H Humeida; Usama R Abdelmohsen; Tobias A Oelschlaeger
Journal:  Front Microbiol       Date:  2018-07-11       Impact factor: 5.640

6.  Transcriptome Analyses of Candida albicans Biofilms, Exposed to Arachidonic Acid and Fluconazole, Indicates Potential Drug Targets.

Authors:  Oluwasegun Kuloyo; Ruan Fourie; Errol Cason; Jacobus Albertyn; Carolina H Pohl
Journal:  G3 (Bethesda)       Date:  2020-09-02       Impact factor: 3.154

Review 7.  Marine-Derived Compounds and Prospects for Their Antifungal Application.

Authors:  Joana Cardoso; Darlan Gonçalves Nakayama; Emília Sousa; Eugénia Pinto
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

8.  Topical Formulation Comprising Fatty Acid Extract from Cod Liver Oil: Development, Evaluation and Stability Studies.

Authors:  Biljana Ilievska; Thorsteinn Loftsson; Martha Asdis Hjalmarsdottir; Gudrun Marta Asgrimsdottir
Journal:  Mar Drugs       Date:  2016-06-01       Impact factor: 5.118

9.  Herring Oil and Omega Fatty Acids Inhibit Staphylococcus aureus Biofilm Formation and Virulence.

Authors:  Yong-Guy Kim; Jin-Hyung Lee; Chaitany J Raorane; Seong T Oh; Jae G Park; Jintae Lee
Journal:  Front Microbiol       Date:  2018-06-15       Impact factor: 5.640

Review 10.  Marine Macroalgae, a Source of Natural Inhibitors of Fungal Phytopathogens.

Authors:  Tânia F L Vicente; Marco F L Lemos; Rafael Félix; Patrícia Valentão; Carina Félix
Journal:  J Fungi (Basel)       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.